Evaxion Biotech A/S ADR (NASDAQ:EVAX)’s traded shares stood at 0.49 million during the last session, with the company’s beta value hitting -0.28. At the close
In the last trading session, 62.71 million Evaxion Biotech A/S ADR (NASDAQ:EVAX) shares changed hands as the company’s beta touched -0.28. With the company’s per
In the last trading session, 2.77 million Evaxion Biotech A/S ADR (NASDAQ:EVAX) shares changed hands as the company’s beta touched -0.27. With the company’s per
In last trading session, Evaxion Biotech A/S ADR (NASDAQ:EVAX) saw 1.35 million shares changing hands with its beta currently measuring -0.24. Company’s recent per share
In recent trading session, Evaxion Biotech A/S ADR (NASDAQ:EVAX) saw 0.76 million shares changing hands at last check today with its beta currently measuring -0.24.
Evaxion Biotech A/S ADR (NASDAQ:EVAX) has a beta value of -0.09 and has seen 3.28 million shares traded in the last trading session. The company,
Evaxion Biotech A/S ADR (NASDAQ:EVAX) has a beta value of -0.24 and has seen 55.64 million shares traded in the last trading session. The company,
During the last session, Evaxion Biotech A/S ADR (NASDAQ:EVAX)’s traded shares were 3.6 million, with the beta value of the company hitting -0.30. At the
In the last trading session, 59426.0 shares of the Evaxion Biotech A/S ADR (NASDAQ:EVAX) were traded, and its beta was -0.22. Most recently the company’s
In last trading session, Evaxion Biotech A/S ADR (NASDAQ:EVAX) saw 0.22 million shares changing hands with its beta currently measuring -0.23. Company’s recent per share
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
